Trials / Completed
CompletedNCT03177278
A Study to Assess the Metabolism, Excretion, and Mass Balance of Radio-Labeled Plazomicin
A Phase 1, Open-Label Study to Assess the Metabolism, Excretion, and Mass Balance of [14C]-Plazomicin Following a Single IV Infusion in Healthy Adult Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Achaogen, Inc. · Industry
- Sex
- Male
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a single-center, open label, non-randomized metabolism, excretion, and mass balance study of a single IV infusion of \[14C\]-plazomicin in healthy, adult male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]-plazomicin | single intravenous dose |
Timeline
- Start date
- 2017-06-16
- Primary completion
- 2017-07-10
- Completion
- 2017-07-10
- First posted
- 2017-06-06
- Last updated
- 2017-07-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03177278. Inclusion in this directory is not an endorsement.